Allen & Overy advised Shandong Boan Biotechnology Co., Ltd. on the deal. The transaction involed the spin-off from Luye Pharma Group (2186.HK) and a separate listing of...
You must be a Standard 1 Year member to access this content.
Allen & Overy and Harneys acted for Vivere Lifesciences Acquisition Corp. On 21 February, 2022, Vivere Lifesciences Acquisition Corporation submitted its listing application for the Main Board of the Hong...
You must be a Standard 1 Year member to access this content.
Allen & Overy advised Zhongsheng Group Holdings Limited on the deal. Zhongsheng Group Holdings Limited (Zhongsheng), a leading automobile distribution group in China, acquired Zung Fu...
You must be a Standard 1 Year member to access this content.
